Teva Pharmaceutical Industries (TEVA) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Teva Pharmaceutical Industries Revenue Highlights


Latest Revenue (Y)

$15.85B

Latest Revenue (Q)

$4.16B

Main Segment (Y)

International Markets

Main Geography (Y)

North America

Teva Pharmaceutical Industries Revenue by Period


Teva Pharmaceutical Industries Revenue by Year

DateRevenueChange
2023-12-31$15.85B6.17%
2022-12-31$14.93B-6.00%
2021-12-31$15.88B-4.68%
2020-12-31$16.66B-1.36%
2019-12-31$16.89B-10.43%
2018-12-31$18.85B-15.77%
2017-12-31$22.39B2.20%
2016-12-31$21.90B11.45%
2015-12-31$19.65B-3.06%
2014-12-31$20.27B-0.21%
2013-12-31$20.31B-0.01%
2012-12-31$20.32B10.95%
2011-12-31$18.31B13.59%
2010-12-31$16.12B15.99%
2009-12-31$13.90B25.39%
2008-12-31$11.09B17.83%
2007-12-31$9.41B11.89%
2006-12-31$8.41B60.14%
2005-12-31$5.25B9.41%
2004-12-31$4.80B46.47%
2003-12-31$3.28B30.09%
2002-12-31$2.52B21.24%
2001-12-31$2.08B18.72%
2000-12-31$1.75B36.45%
1999-12-31$1.28B14.92%
1998-12-31$1.12B-0.09%
1997-12-31$1.12B17.10%
1996-12-31$953.80M42.85%
1995-12-31$667.70M13.61%
1994-12-31$587.70M17.07%
1993-12-31$502.00M-

Teva Pharmaceutical Industries generated $15.85B in revenue during NA 2023, up 6.17% compared to the previous quarter, and up 84.05% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue by Quarter

DateRevenueChange
2024-06-30$4.16B8.66%
2024-03-31$3.83B-14.02%
2023-12-31$4.46B15.77%
2023-09-30$3.85B-0.72%
2023-06-30$3.88B5.93%
2023-03-31$3.66B-5.74%
2022-12-31$3.88B8.04%
2022-09-30$3.60B-5.02%
2022-06-30$3.79B3.39%
2022-03-31$3.66B-10.71%
2021-12-31$4.10B5.51%
2021-09-30$3.89B-0.61%
2021-06-30$3.91B-1.81%
2021-03-31$3.98B-10.56%
2020-12-31$4.45B11.92%
2020-09-30$3.98B2.79%
2020-06-30$3.87B-11.18%
2020-03-31$4.36B-2.48%
2019-12-31$4.47B4.78%
2019-09-30$4.26B-1.68%
2019-06-30$4.34B0.98%
2019-03-31$4.29B-5.79%
2018-12-31$4.56B0.66%
2018-09-30$4.53B-3.66%
2018-06-30$4.70B-7.19%
2018-03-31$5.07B-7.22%
2017-12-31$5.46B-2.69%
2017-09-30$5.61B-1.34%
2017-06-30$5.69B0.99%
2017-03-31$5.63B-13.28%
2016-12-31$6.49B16.70%
2016-09-30$5.56B10.42%
2016-06-30$5.04B4.74%
2016-03-31$4.81B-1.45%
2015-12-31$4.88B1.20%
2015-09-30$4.82B-2.88%
2015-06-30$4.97B-0.32%
2015-03-31$4.98B-3.60%
2014-12-31$5.17B2.17%
2014-09-30$5.06B0.26%
2014-06-30$5.04B0.88%
2014-03-31$5.00B-7.90%
2013-12-31$5.43B7.33%
2013-09-30$5.06B2.74%
2013-06-30$4.92B0.47%
2013-03-31$4.90B-6.63%
2012-12-31$5.25B5.57%
2012-09-30$4.97B-0.44%
2012-06-30$4.99B-2.12%
2012-03-31$5.10B-10.11%
2011-12-31$5.68B30.66%
2011-09-30$4.34B3.13%
2011-06-30$4.21B3.24%
2011-03-31$4.08B-7.65%
2010-12-31$4.42B3.95%
2010-09-30$4.25B11.84%
2010-06-30$3.80B4.02%
2010-03-31$3.65B-3.92%
2009-12-31$3.80B7.10%
2009-09-30$3.55B4.41%
2009-06-30$3.40B8.04%
2009-03-31$3.15B10.50%
2008-12-31$2.85B0.21%
2008-09-30$2.84B0.67%
2008-06-30$2.82B9.76%
2008-03-31$2.57B-

Teva Pharmaceutical Industries generated $4.16B in revenue during Q2 2024, up 8.66% compared to the previous quarter, and up 113.74% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue Breakdown


Teva Pharmaceutical Industries Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
International Markets$1.96B$1.90B$2.03B$2.15B$2.25B
Other Activities$926.00M$1.04B$1.15B$1.30B$1.30B

Teva Pharmaceutical Industries's latest annual revenue breakdown by segment (product or service), as of Dec 23: International Markets (67.89%), and Other Activities (32.11%).

Quarterly Revenue by Product

Product/ServiceJun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Distribution Service$382.00M-------------------
Product and Service, Other$106.00M-------------------
Product$3.64B-------------------
License$36.00M-------------------
Other Activities-$462.00M$245.00M$219.00M$272.00M$241.00M$257.00M$275.00M$302.00M$262.00M$298.00M$289.00M$345.00M$316.00M$335.00M$307.00M$332.00M$314.00M--
International Markets-$987.00M$479.00M$492.00M$481.00M$475.00M$454.00M$492.00M$527.00M$530.00M$485.00M$490.00M$572.00M$529.00M$488.00M$565.00M$101.00M$736.00M--
Austedo------------------$96.00M-
AJOVY------------------$23.00M-
Anda------------------$351.00M-
Pro Air------------------$65.00M-
QVAR------------------$60.00M-
TREANDA and BENDEKA------------------$115.00M-
Distribution-------------------$151.00M

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (87.42%), Distribution Service (9.17%), Product and Service, Other (2.55%), and License (0.86%).

Teva Pharmaceutical Industries Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
North America$8.12B$5.83B$6.39B$6.90B$6.94B
Europe$4.84B$4.46B$4.81B$4.74B$4.77B

Teva Pharmaceutical Industries's latest annual revenue breakdown by geography, as of Dec 23: North America (62.68%), and Europe (37.32%).

Quarterly Revenue by Country

CountryJun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
UNITED STATES$2.11B-------------------
Europe$1.21B$2.51B$1.15B$1.18B$1.16B$1.03B$1.13B$1.13B$1.25B$1.20B$1.19B$1.18B$1.25B$7.00M$1.00B$1.37B$7.00M$1.15B$1.17B$1.26B
North America-$5.23B$1.58B$1.32B$1.53B$1.39B$1.54B$1.38B$1.62B$1.49B$1.62B$1.67B$1.96B$1.66B$1.66B$1.63B$1.94B$1.67B$1.69B$1.64B

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (63.50%), and Europe (36.50%).

Teva Pharmaceutical Industries Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TAKTakeda Pharmaceutical Company$4.26T$1.05T
TEVATeva Pharmaceutical Industries$15.85B$4.16B
VTRSViatris$15.43B$3.66B
HLNHaleon$11.30B$2.92B
BHCBausch Health Companies$8.76B$2.51B
ZTSZoetis$8.54B$2.36B
ELANElanco Animal Health$4.42B$1.21B
CTLTCatalent$4.38B$1.07B
SNDLSNDL$909.01M$197.75M
TLRYTilray Brands$788.94M$200.04M
CGCCanopy Growth$297.15M$75.78M
ACBAurora Cannabis$233.29M$64.42M
HEXOHEXO$191.10M$21.59M
LFCRLifecore Biomedical$128.26M$24.70M
CRONCronos Group$120.27M$38.68M
LSDILucy Scientific Discovery$7.05K$9.68K
SHPHShuttle Pharmaceuticals--

TEVA Revenue FAQ


Teva Pharmaceutical Industries's yearly revenue for 2023 was $15.85B, representing an increase of 6.17% compared to 2022. The company's yearly revenue for 2022 was $14.92B, representing a decrease of -6.00% compared to 2021. TEVA's yearly revenue for 2021 was $15.88B, representing a decrease of -4.68% compared to 2020.

Teva Pharmaceutical Industries's quarterly revenue for Q2 2024 was $4.16B, a 8.66% increase from the previous quarter (Q1 2024), and a 7.37% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.83B, a -14.02% decrease from the previous quarter (Q4 2023), and a 4.67% increase year-over-year (Q1 2023). TEVA's quarterly revenue for Q4 2023 was $4.46B, a 15.77% increase from the previous quarter (Q3 2023), and a 14.75% increase year-over-year (Q4 2022).

Teva Pharmaceutical Industries's revenue growth rate for the last 3 years (2021-2023) was -0.20%, and for the last 5 years (2019-2023) was -6.16%.

Teva Pharmaceutical Industries's revenue streams in c 23 are International Markets, and Other Activities. International Markets generated $1.96B in revenue, accounting 67.89% of the company's total revenue, up 2.89% year-over-year. Other Activities generated $926M in revenue, accounting 32.11% of the company's total revenue, down -11.39% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Teva Pharmaceutical Industries was International Markets. This segment made a revenue of $1.96B, representing 67.89% of the company's total revenue.